Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells
Open Access
- 15 August 1998
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 161 (4), 1947-1953
- https://doi.org/10.4049/jimmunol.161.4.1947
Abstract
This study identifies type I IFNs as activating cytokines in a serum-free system in which human dendritic cells (DC) were generated from CD34+ progenitor cells. After 14 days of culture in GM-CSF, TNF-α, and IL-4, CD34+ progenitors gave rise to a population of large, immature DC expressing CD1a and CD11b but lacking CD14, CD80, CD83, CD86, and CMRF44. During the next 2 wk, this population spontaneously matured into nonadherent, CD1alow/−, CD11blow/−, CD14−, CD80+, CD83+, CD86+, CMRF44+ DC with high allostimulatory activity in the MLR. To examine which factors influenced this maturation, 25 different cytokines or factors were added to the immature DC culture. Only type I IFNs (α or β) accelerated this maturation in a dose-dependent manner, so that after only 3 days the majority of large cells acquired the morphology, phenotype, and function characteristics of mature DC. Furthermore, supernatants from cultures containing spontaneously maturing DC revealed low levels of endogenous IFN production. Because of the similarity of the activation of DC in our culture system with the phenotypic and functional changes observed during Langerhans cells activation and migration in vivo, we investigated the effect of IFN-α on human Langerhans cell migration. IFN-α also activated the migration of human split skin-derived DC, demonstrating that this effect was not limited to DC derived in vitro from hemopoietic progenitor cells. DC activation by type I IFNs represents a novel mechanism of immunomodulation by these cytokines, which could be important during antiviral responses and autoimmune reactions.Keywords
This publication has 41 references indexed in Scilit:
- IFN‐α1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 miceInternational Journal of Cancer, 1995
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alphaClinical and Experimental Immunology, 1992
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- Intermittent interferonemia and interferon responses in multiple sclerosisClinical Immunology and Immunopathology, 1991
- Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α TreatmentActa Oncologica, 1991
- Human Epidermal Langerhans Cells Undergo Profound Morphologic and Phenotypical Changes During In Vitro CultureJournal of Investigative Dermatology, 1990
- Epidermal Langerhans cells are derived from cells originating in bone marrowNature, 1979
- Mouse epidermal Ia molecules have a bone marrow originNature, 1979